FortuneOne of the most shorted stocks on the market just leapt 99%, putting a 'rib-crunching' squeeze on bearish bettorsMay 10Carmen Reinicke & Angel AdegbesanBy Carmen Reinicke & Angel Adegbesanmore_vert
Financial TimesSanofi licensing deal doubles value of vaccine group NovavaxMay 10Oliver BarnesBy Oliver Barnesmore_vert
PR NewswireNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and ...May 10more_vert
The Motley FoolNovavax Stock Just Tripled. Is It Too Late to Buy?May 15Adria CiminoBy Adria Ciminomore_vert
STATSanofi strikes deal with Novavax, boosting the vaccine makerMay 10Andrew JosephBy Andrew Josephmore_vert
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for companyMay 10Anjalee KhemlaniBy Anjalee Khemlanimore_vert
CNBCNovavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shotsMay 10Annika Kim ConstantinoBy Annika Kim Constantinomore_vert
ReutersNovavax shares soar on license deal with Sanofi at lofty valuationMay 10Patrick Wingrove & Bhanvi SatijaBy Patrick Wingrove & Bhanvi Satijamore_vert
CNBCNovavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine makerMay 13Annika Kim ConstantinoBy Annika Kim Constantinomore_vert